SG Americas Securities LLC Sells 182,938 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

SG Americas Securities LLC trimmed its stake in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 95.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,701 shares of the company's stock after selling 182,938 shares during the period. SG Americas Securities LLC's holdings in Core Scientific were worth $115,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. P Schoenfeld Asset Management LP acquired a new stake in shares of Core Scientific during the second quarter worth $4,185,000. Vanguard Group Inc. acquired a new stake in Core Scientific in the 1st quarter valued at $21,973,000. Hexagon Capital Partners LLC acquired a new stake in Core Scientific in the 1st quarter valued at $34,000. Blair William & Co. IL acquired a new stake in Core Scientific in the 1st quarter valued at $1,156,000. Finally, DeepCurrents Investment Group LLC increased its stake in Core Scientific by 157.7% in the 2nd quarter. DeepCurrents Investment Group LLC now owns 255,162 shares of the company's stock valued at $2,373,000 after buying an additional 156,162 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. LADENBURG THALM/SH SH reiterated a "buy" rating and issued a $14.50 price target on shares of Core Scientific in a research note on Tuesday, July 2nd. Sanford C. Bernstein reiterated an "outperform" rating and issued a $17.00 price target on shares of Core Scientific in a research note on Tuesday, September 10th. Macquarie assumed coverage on shares of Core Scientific in a research note on Wednesday, September 25th. They issued an "outperform" rating and a $16.00 price target on the stock. Canaccord Genuity Group lifted their price target on shares of Core Scientific from $16.00 to $17.00 and gave the company a "buy" rating in a research note on Wednesday. Finally, Canaccord Genuity Group assumed coverage on shares of Core Scientific in a research report on Monday, September 23rd. They issued a "buy" rating and a $16.00 price objective for the company. Eleven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Core Scientific currently has an average rating of "Buy" and a consensus target price of $16.50.

Insider Buying and Selling

In other Core Scientific news, CFO Denise Marie Brucia Sterling sold 8,752 shares of the business's stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $82,356.32. Following the completion of the sale, the chief financial officer now owns 122,217 shares of the company's stock, valued at $1,150,061.97. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, insider Todd M. Duchene sold 11,582 shares of the business's stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $108,986.62. Following the completion of the transaction, the insider now directly owns 1,686,474 shares in the company, valued at approximately $15,869,720.34. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Denise Marie Brucia Sterling sold 8,752 shares of the company's stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $9.41, for a total transaction of $82,356.32. Following the transaction, the chief financial officer now owns 122,217 shares of the company's stock, valued at approximately $1,150,061.97. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders purchased 12,761 shares of company stock valued at $127,080. Company insiders own 32.00% of the company's stock.

Core Scientific Stock Performance

Shares of CORZ stock traded down $0.31 during midday trading on Friday, hitting $13.37. 7,911,332 shares of the company were exchanged, compared to its average volume of 8,680,838. The firm's 50 day moving average price is $11.57 and its two-hundred day moving average price is $8.65. Core Scientific, Inc. has a 52 week low of $2.61 and a 52 week high of $14.06.

Core Scientific (NASDAQ:CORZ - Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported ($4.51) EPS for the quarter, missing the consensus estimate of ($0.04) by ($4.47). The company had revenue of $141.10 million for the quarter, compared to analyst estimates of $128.58 million. The firm's quarterly revenue was up 11.2% on a year-over-year basis. On average, sell-side analysts predict that Core Scientific, Inc. will post 0.01 earnings per share for the current year.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.